ISPOR EU 2021

Check Out Our Accepted Posters

Poster 1: Impact of COVID-19 on Influenza Vaccine Sales in France, United Kingdom and United States

The objective of this study was to evaluate the impact of COVID-19 on influenza vaccines sales.

Authors:

• Armel Ngami (Syneos Health), Thomas Christie (InfoAccess), G. Ménin (Sanofi Pasteur), Florent Guelfucci (Syneos Health), Florence Bianic (Syneos Health), Pierre Net (Syneos Health)

Poster 2: Public Health and Economic Impact of Influenza Immunization by Pharmacists: A Systematic Literature Review and Analysis of the French Experience

We conducted a systematic literature review (SLR) to assess the public health and economic impact of influenza immunization by pharmacists to inform what could be the expected outcomes in France.

Authors:

• Darina Proshenska (Syneos Health), Géraldine Ménin (Sanofi Pasteur) , Florence Bianic (Syneos Health) , Pierre Net (Syneos Health)

Poster 3: Economic Impact and Public Health Benefit of Influenza Immunization by Pharmacists in France

We evaluated the public health and economic impact of influenza vaccination by pharmacists using a budget impact model.

Authors: 

• Mafalda Costa  (Syneos Health), Géraldine Ménin (Sanofi Pasteur), FP. Alvarez (Sanofi Pasteur), Florence Bianic (Syneos Health), Pierre Net (Syneos Health)

Poster 4: Impact of the COVID-19 Pandemic on Influenza Vaccination Policies

The objective of this study was to evaluate the impact of the COVID-19 pandemic on influenza vaccination policies.

Authors:

• Pierre Net (Syneos Health) , Javier de Renteria (Syneos Health), Florence Bianic (Syneos Health)

Poster 5: Impact of COVID-19 on Surgical Activity: Experience from a French University Teaching Hospital

This study aimed at quantifying the impact of COVID-19 and lockdowns on surgical activity in a French university teaching hospital.

Authors:

• Léo Cazin (Ambroise Paré Hospital),  Armel Ngami (Syneos Health), Louise Parenne (Ambroise Paré Hospital)

Poster 6: Impact of COVID-19 on Influenza Vaccine Coverage Rate during the 2020/2021 Season

The objective of this study was to assess the evolution of influenza vaccine coverage rate (VCR) under the COVID-19 pandemic.

Authors:

• Armel Ngami (Syneos Health), Florent Guelfucci (Syneos Health), Florence Bianic (Syneos Health), Pierre Net (Syneos Health)

Poster 7: Healthcare Resource Utilization (HRU) Survey to Inform HRU DATA Collection Alongside the Double-Blinded Trilynx Study Evaluating Xevinapant in Combination with Chemoradiotherapy Versus PlaceboPLUS Chemoradiotherapy in Patients with Previously Untreated Locally-Advanced Squamous Cell Carcinoma of the Head and Neck (LA SCCHN)​

The aim of the survey was to inform HRU data collection in the Phase 3 trial as limited HRU data are available from the literature in SCCHN.

Authors:

• Erwin De Cock (Syneos Health) & Carla Vossen (Syneos Health)

​

Poster 8: Workflow Mapping of the Paediatric Hexavalent Immunisation Process in the United Kingdom (UK) to Inform Feasibility of a Time and Motion Study

The observational T&M study will generate time data that are more robust than the opinion-based estimates presented.

Authors:

• Erwin De Cock (Syneos Health) & Carla Vossen (Syneos Health)

Register Now